New combo therapy tested for rare blood disorder
Disease control
Not yet recruiting
This study is testing whether a new drug called gecacitinib, when combined with an existing medication (pegylated interferon), can help control polycythemia vera. Researchers want to see if this combination can bring blood counts back to normal levels and reduce symptoms like fat…
Phase: NA • Sponsor: Duan Minghui • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC